GlobeNewsWire
24 Mar 2026, 20:05 UTC · 29w ago
Verdict
Headline takes no side. We score BMEA +0.80 — strongly bullish.
+0.80strongly bullish
More positive than 89% of ticker scores this week
Which stocks this story touches
More positive than 89% of ticker scores this week
The company reported positive clinical activity for icovamenib, progress in GLP-1 trials, and a clear cash runway into 2027.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
4h ago
+11.5%
Price agrees with the score
$1.26 vs $1.13 close before publication (Mar 24) · not market-adjusted
BMEA chart →
